Darsana Capital Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$429M Buy
1,100,000
+350,000
+47% +$148M 1.93% 6
2026
Q1
$355M Sell
750,000
-250,000
-25% -$126M 7.56% 6
2025
Q4
$467M Hold
1,000,000
9.3% 4
2025
Q3
$426M Hold
1,000,000
10.04% 4
2025
Q2
$383M Sell
1,000,000
-250,000
-20% -$90.1M 10.94% 2
2025
Q1
$432M Buy
1,250,000
+25,000
+2% +$8.04M 12.55% 1
2024
Q4
$368M Buy
1,225,000
+75,000
+7% +$26.2M 11.19% 3
2024
Q3
$467M Hold
1,150,000
11.51% 1
2024
Q2
$369M Buy
1,150,000
+400,000
+53% +$130M 10.1% 4
2024
Q1
$250M Buy
+750,000
New +$229M 8.04% 7

Other funds holding HCA

Darsana Capital Partners's HCA Position: Q2 2026 in Review

Darsana Capital Partners increased its HCA Healthcare (HCA) stake by 47% in Q2 2026, buying an estimated $148M and bringing the position to 1,100,000 shares worth $429M. The position accounts for 1.93% of the portfolio, ranked #6.

Darsana Capital Partners first reported a position in HCA in Q1 2024 and has held it in 10 quarters since. The position peaked at $467M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Darsana Capital Partners held 1,100,000 shares of HCA Healthcare worth $429M as of Q2 2026.
  • Darsana Capital Partners bought 350,000 HCA Healthcare shares in Q2 2026, an estimated $148M.
  • HCA Healthcare made up 1.93% of Darsana Capital Partners's portfolio in Q2 2026, its #6 holding.
  • Darsana Capital Partners first reported a position in HCA Healthcare in Q1 2024 and has held it in 10 quarters since.
  • Darsana Capital Partners's HCA Healthcare position peaked at $467M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Darsana Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.